Physiologically-based Pharmacokinetic Modeling for Assessment of the Drug-drug Interaction Potential of Zavegepant

Treatment with Zavegepant Offers Improvements in Pain Severity Over 48-hours When Compared with Placebo—Post Hoc Results from a Randomized Placebo-controlled Trial (BHV3500-301)